ASO Author Reflections: Risk for Three-Course Neoadjuvant Chemotherapy in Advanced Esophageal Cancer.

Kubo, Yuto; Makino, Tomoki; Doki, Yuichiro

Kubo, Yuto; Makino, Tomoki; Doki, Yuichiro.

Afiliação

Kubo Y; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan.
Makino T; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan. tmakino@gesurg.med.osaka-u.ac.jp.
Doki Y; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan.

Ann Surg Oncol ; 30(9): 5908-5909, 2023 09.

Article em En | MEDLINE | ID: mdl-37289268

Assuntos

Neoplasias Esofágicas; Terapia Neoadjuvante; Humanos; Neoplasias Esofágicas/tratamento farmacológico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Terapia Neoadjuvante Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Ann Surg Oncol Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google